Dabigatran etexilate (Pradaxa®) associated with significantly lower rates of fatal and traumatic intracranial haemorrhage compared with Warfarin
18 April 2012 | By Boehringer Ingelheim
A new analysis of the 18,113 patient...
List view / Grid view
18 April 2012 | By Boehringer Ingelheim
A new analysis of the 18,113 patient...
Bringing new insect silk products to the global market is the focus of a partnership announced today by Australian research agency CSIRO and global life science industry supplier Lonza.
18 April 2012 | By Merck
Merck said a state court jury in New Jersey found in its favor in the Sessner v. Merck case...
18 April 2012 | By Gilead Sciences
Presentations include first results for lead hepatitis C candidate GS-7977 in treatment-naïve genotype 1 patients...
17 April 2012 | By Abbott
Detection of gene abnormalities may help men determine the best approach to treatment...
17 April 2012 | By Novo Nordisk
Novo Nordisk broke ground on a new USD 100 million plant that will formulate and fill modern insulin into Novo Nordisk’s Penfill® cartridges...
17 April 2012 | By Tecan
Tecan’s Infinite® M1000 plate reader has enabled researchers at the Institute of Entomology (ENTU)...
17 April 2012 | By Abbott
Statistically significant improvements...
17 April 2012 | By Catalent Pharma Solutions
Norman Weichbrodt, Research & Development Strategic Account Manager for Catalent Pharma Solutions will present “Advanced Aseptic Processing using Blow/Fill/Seal Technology” at Pharma Congress 2012 in Dusseldorf, Germany on Tuesday, April 24, 2012.
16 April 2012 | By Eli Lilly and Company
Lilly Diabetes & Walgreens to help combat the problem of hypoglycemia unawareness...
16 April 2012 | By Catalent Pharma Solutions
Nascent and Catalent announced the signing of a product development agreement...
16 April 2012 | By Karen Taylor PR
Owen Mumford, one of the UK’s largest manufacturers of medical devices has opened its doors for business in China...
New applications improve the efficiency of microbial quality control processes...
16 April 2012 | By Merck
Vintafolide is currently being evaluated in a Phase III clinical trial...
13 April 2012 | By HORIBA Scientific
Bio-Rad’s KnowItAll® Informatics System software offered for use with the HORIBA Scientific range of Raman spectrometers...